SENSEX NIFTY
75311.06 22795.9
-424.90 (-0.56%)
-117.25 (-0.51%)
 

NOTICES


Heading View
  SEBI Circular No. CIR/MRD/DP/01/2014 Dated 7th January, 2014   Click here
  SEBI Circular No. SEBI/HO/MIRSD/MIRSD2/CIR/P/2016/95, Dated 26th September, 2016.   Click here
DETACH
Increase
Minus
Hot Pursuit Back
Pfizer partners with Mylan for marketing of Ativan and Pacitane
(21 Feb 2025, 15:25)
The agreement is for a period of five years and applies within the territory of India.

Mylan has a strong presence in the Central Nervous System (CNS) therapy area, supported by skilled resources that engage with super specialists such as neurologists and psychiatrists. This collaboration with Mylan will enhance the distribution and in-clinic presence of Pfizer's products.

Pfizer is involved in the manufacturing, marketing, trading, and export of pharmaceutical products.

The pharma company's net profit rose 2.8% to Rs 127.60 crore in Q3 FY25 as against Rs 124.11 crore recorded in Q3 FY24. Revenue from operations shed 0.4% year on year to Rs 537.99 crore during the quarter.

Shares of Pfizer shed 0.41% to Rs 4,095.55 on the BSE.

Powered by Capital Market - Live News

 
Attention Investors: No need to issue cheques by investors while subscribing to IPO. just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account. | Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.' "
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Dear Clients: We are here with requesting you to submit your separate e-mail id to receive communications/reports, by submitting account modification form in this regards or if you have registered your family member e-mail id with us, please submit declaration in this regards. Further, if you have not registered e-mail id/mobile number with us, please register it by submitting account modification form which facilitates you to receive all the data/reports electronically. If you require any clarification, please feel free to call Mr. Hemant Shah on 9004603818 or email us at kyc@swcapital.in
Feedback | Back Office | Downloads | KYC | Disclaimer | Privacy Policy | Investor Grievances | Communique | Tariff Structure |
SCORES| Opening A Account| Filing A Complaints|
Copyright © 2011 -SW Capital Pvt Ltd. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)